中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
12期
2064-2065
,共2页
顾建伟%谢争鸣%夏丽%丁元华%孟咸中
顧建偉%謝爭鳴%夏麗%丁元華%孟鹹中
고건위%사쟁명%하려%정원화%맹함중
滋泉口服液%空腹血糖受损%胰岛功能%中医药疗法%消渴
滋泉口服液%空腹血糖受損%胰島功能%中醫藥療法%消渴
자천구복액%공복혈당수손%이도공능%중의약요법%소갈
目的:本课题旨在观察滋泉口服液干预空腹血糖受损的临床疗效。方法:将120例IFG患者进行随机、对照、单盲方法分组进行干预治疗,治疗组和对照组研究对象各60名,对照组患者给予基础治疗:即视患者个体情况给予饮食和运动疗法。治疗组患者在基础干预的基础上,口服滋泉口服液,叮嘱患者每天2次口服滋泉口服液,3个月为一疗程,共观察2个疗程,通过监测血糖(空腹和餐后2小时)、血清甘油三酯、胆固醇、尿酸等指标,判定滋泉口服液干预IFG的临床疗效。结果:经过治疗6个月后,对照组治疗前后在FPG.TC及TG相比有差异(P<0.05),治疗前后对照组组患者的2hPG相比较差异没有统计学意义(P>0.05),治疗前后对照组组患者的及UA相比没有差异(P>0.05);治疗组患者在治疗前后FPG、TC、及TG相比有显著性差异(P<0.01),治疗前后2hPG及UA相比有差异(P<0.05);治疗后两组在FPG、TC及TG相比有差异(P<0.05)。结论:滋泉口服液能降低空腹血糖、餐后2小时血糖、改善血脂水平,可有效干预IFG。
目的:本課題旨在觀察滋泉口服液榦預空腹血糖受損的臨床療效。方法:將120例IFG患者進行隨機、對照、單盲方法分組進行榦預治療,治療組和對照組研究對象各60名,對照組患者給予基礎治療:即視患者箇體情況給予飲食和運動療法。治療組患者在基礎榦預的基礎上,口服滋泉口服液,叮囑患者每天2次口服滋泉口服液,3箇月為一療程,共觀察2箇療程,通過鑑測血糖(空腹和餐後2小時)、血清甘油三酯、膽固醇、尿痠等指標,判定滋泉口服液榦預IFG的臨床療效。結果:經過治療6箇月後,對照組治療前後在FPG.TC及TG相比有差異(P<0.05),治療前後對照組組患者的2hPG相比較差異沒有統計學意義(P>0.05),治療前後對照組組患者的及UA相比沒有差異(P>0.05);治療組患者在治療前後FPG、TC、及TG相比有顯著性差異(P<0.01),治療前後2hPG及UA相比有差異(P<0.05);治療後兩組在FPG、TC及TG相比有差異(P<0.05)。結論:滋泉口服液能降低空腹血糖、餐後2小時血糖、改善血脂水平,可有效榦預IFG。
목적:본과제지재관찰자천구복액간예공복혈당수손적림상료효。방법:장120례IFG환자진행수궤、대조、단맹방법분조진행간예치료,치료조화대조조연구대상각60명,대조조환자급여기출치료:즉시환자개체정황급여음식화운동요법。치료조환자재기출간예적기출상,구복자천구복액,정촉환자매천2차구복자천구복액,3개월위일료정,공관찰2개료정,통과감측혈당(공복화찬후2소시)、혈청감유삼지、담고순、뇨산등지표,판정자천구복액간예IFG적림상료효。결과:경과치료6개월후,대조조치료전후재FPG.TC급TG상비유차이(P<0.05),치료전후대조조조환자적2hPG상비교차이몰유통계학의의(P>0.05),치료전후대조조조환자적급UA상비몰유차이(P>0.05);치료조환자재치료전후FPG、TC、급TG상비유현저성차이(P<0.01),치료전후2hPG급UA상비유차이(P<0.05);치료후량조재FPG、TC급TG상비유차이(P<0.05)。결론:자천구복액능강저공복혈당、찬후2소시혈당、개선혈지수평,가유효간예IFG。
Objective:the purpose of this paper is to observe the clinical efficacy of intervention Ziquan oral liquid impaired fasting glucose. Methods:120 cases of IFG were divided into two groups randomly, the control method, single blind intervention therapy, the treatment group and the control group with 60 cases in each group, the control group received basic intervention:arrangement of diet and exercise plan according to the individual situation, the significance of propaganda to diet and exercise. Treatment group was given based intervention and oral Ziquan oral liquid:arrangement of diet and exercise plan according to the individual situation, significance and oral Ziquan oral liquid propaganda diet and exercise, 2 times per day, 20ml, followed in June, 3 months for a course, 2 courses were observed, by monitoring blood glucose (fasting 2 hours and after dinner), serum triglyceride, cholesterol, uric acid index, clinical curative intervention Ziquan oral liquid IFG. Results:Between the two groups before and after treatment by the determination of fasting blood glucose, 2h postprandial blood glucose, serum triglyceride, cholesterol, uric acid and other indicators, and statistical test. After 6 months after the treatment, control group before and after treatment in the FPG.TC and TG differences (P<0.05), and UA 2hPG before and after treatment compared with no difference (P>0.05);the treatment group before and after treatment, TC, FPG and TG had significant difference (P<0.01), and UA 2hPG before and after treatment compared with difference (P<0.05 );the two groups after treatment in the FPG, TC and TG differences (P<0.05). Conclusion:Zi Quan oral liquid can reduce fasting blood glucose, postprandial 2 hour blood glucose, improve lipid levels, which can effectively interfere with IFG.